Yi-Ke Deng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yi-Ke Deng has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Zheng Liu
Department of Otolaryngology Zhongnan Hospital of Wuhan University Wuhan Hubei China
4 shared publications - Jin Ma
Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3 shared publications - Li Pan
Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3 shared publications - Bei Guo
Department of Otolaryngology-Head and Neck Surgery, Wuhan Central Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2 shared publications - Cai-Ling Chen
Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2 shared publications - Ke-Zhang Zhu
Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 17 (1) , 147-148
Erratum: Inflammatory Endotypes and Tissue Remodeling Features in Antrochoanal Polyps
Chen CL, et al. Allergy Asthma Immunol Res. 2025 Jan;17(1):147-148. https://doi.org/10.4168/aair.2025.17.1.147
- 1 January 2025
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 17 (1) , 147-148
Open AccessErratum: Inflammatory Endotypes and Tissue Remodeling Features in Antrochoanal Polyps
Chen CL, et al. Allergy Asthma Immunol Res. 2025 Jan;17(1):147-148. https://doi.org/10.4168/aair.2025.17.1.147
- 29 November 2022
- Published by Elsevier in Journal of Infection
- Vol. 86 (2) , 154-225
Persistent olfactory dysfunction 2 years after onset of COVID-19
- 29 November 2022
- Published by Elsevier in Journal of Infection
- Vol. 86 (2) , 154-225
Persistent olfactory dysfunction 2 years after onset of COVID-19
- Open Access
- 1 January 2021
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 13 (6) , 863-881
Inflammatory Endotypes and Tissue Remodeling Features in Antrochoanal Polyps
Chen CL, et al. Allergy Asthma Immunol Res. 2021 Nov;13(6):863-881. https://doi.org/10.4168/aair.2021.13.6.863
- 1 January 2021
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 13 (6) , 863-881
Open AccessInflammatory Endotypes and Tissue Remodeling Features in Antrochoanal Polyps
Chen CL, et al. Allergy Asthma Immunol Res. 2021 Nov;13(6):863-881. https://doi.org/10.4168/aair.2021.13.6.863
- Open Access
Self-reported taste and smell disorders in patients with COVID-19:distinct features in China
Objectives: We aimed to explore the frequencies of nasal symptoms in patients with COVID-19, including loss of smell and taste, as well as their presentation as the first symptom of the disease and their association with the severity of COVID-19. Methods: In this retrospective study, 1,206 laboratory-confirmed COVID-19 patients were included and followed-up by telephone call one month after discharged from Tongji Hospital, Wuhan. Demographic data, laboratory values, comorbidities, symptoms, and numerical rating scale scores (0-10) of nasal symptoms were extracted from the hospital medical records, and confirmed or reevaluated by the telephone follow-up. Results: From COVID-19 patients (N = 1,172) completing follow-up, 199 (17%) subjects had severe COVID-19 and 342 (29.2%) reported nasal symptoms. The most common nasal symptom was loss of taste (20.6%, median score = 6), while 11.4% had loss of smell (median score = 5). The incidence of nasal symptom including loss of smell and loss of taste as the first onset symptom was <1% in COVID-19 patients. Loss of smell or taste scores showed no correlation with the scores of other nasal symptoms. Loss of taste scores, but not loss of smell scores, were significantly increased in severe vs. non-severe COVID-19 patients. Interleukin (IL)-6 and lactose dehydrogenase (LDH) serum levels positively correlated with loss of taste scores. About 80% of COVID-19 patients recovered from smell and taste dysfunction in 2 weeks. Conclusion: In the Wuhan COVID-19 cohort, only 1 out of 10 hospital admitted patients had loss of smell while 1 out 5 reported loss of taste which was associated to severity of COVID-19. Most patients recovered smell and taste dysfunctions in 2 weeks.
Open AccessSelf-reported taste and smell disorders in patients with COVID-19:distinct features in China
Objectives: We aimed to explore the frequencies of nasal symptoms in patients with COVID-19, including loss of smell and taste, as well as their presentation as the first symptom of the disease and their association with the severity of COVID-19. Methods: In this retrospective study, 1,206 laboratory-confirmed COVID-19 patients were included and followed-up by telephone call one month after discharged from Tongji Hospital, Wuhan. Demographic data, laboratory values, comorbidities, symptoms, and numerical rating scale scores (0-10) of nasal symptoms were extracted from the hospital medical records, and confirmed or reevaluated by the telephone follow-up. Results: From COVID-19 patients (N = 1,172) completing follow-up, 199 (17%) subjects had severe COVID-19 and 342 (29.2%) reported nasal symptoms. The most common nasal symptom was loss of taste (20.6%, median score = 6), while 11.4% had loss of smell (median score = 5). The incidence of nasal symptom including loss of smell and loss of taste as the first onset symptom was <1% in COVID-19 patients. Loss of smell or taste scores showed no correlation with the scores of other nasal symptoms. Loss of taste scores, but not loss of smell scores, were significantly increased in severe vs. non-severe COVID-19 patients. Interleukin (IL)-6 and lactose dehydrogenase (LDH) serum levels positively correlated with loss of taste scores. About 80% of COVID-19 patients recovered from smell and taste dysfunction in 2 weeks. Conclusion: In the Wuhan COVID-19 cohort, only 1 out of 10 hospital admitted patients had loss of smell while 1 out 5 reported loss of taste which was associated to severity of COVID-19. Most patients recovered smell and taste dysfunctions in 2 weeks.